been obtained by nuclear reprogramming (induced pluripotent stem cells) [7] ; on the other hand, multipotent stem cells have been isolated from the fetus but with high risk of morbidity, and from extra-embryonic tissues (fetal membranes, placenta and umbilical cord blood) [9] . Whereas umbilical cord blood is a source of haematopoietic stem cells, extra-embryonic tissues are utilized as an important source of stem cells with a high potential for differentiation. Among the different populations, multipotent mesenchymal stem cells (MSCs) represent a very promising tool in clinical applications for their differentiating potential towards mesoderm-derived lineage.
More than 120 clinical trials are in progress utilizing MSCs for different therapeutic applications [10, 11] . In clinical practice, the main source of MSCs is adult bone marrow. The percentage of MSCs in the bone marrow, however, is very low (0.001-0.01%), it decreases with age [12] and the retrieval techniques are dangerous. For these reasons it is important to find alternative sources of MSCs, such as extra-embryonic tissues [9] and adipose tissue, which offers a greater number of cells and is easily accessible [13, 14] .
Moreover, MSCs from extra-embryonic sources have intermediate characteristics between ESCs and ASCs [9, 15] . In a recent study, MSCs obtained from 10 samples of chorionic villi showed multipotent properties in common with ESCs [16] . Although MSCs have well-known characteristics [17] , their differences among different sources in terms of gene expression have not been determined yet [18] . It should be really interesting to understand if stem cell potential is reduced during human ontological development.
This topic has been previously explored [19] but the originality of our study derives from the contemporaneous analysis of the three different samples at different stages of human development. The rationale of this experimental study was to understand if MSCs derived from different extra-embryonic tissues, at different stages of human ontological development, presented different stemness potential.
We analyzed the expression of the stem cell master genes OCT-4 (Octamer-binding transcription factor 4, also known as POU5F1), SOX-2 (SRY box-containing factor 2) and NANOG in all samples. Moreover, we evaluated the expression of two other genes, REX-1 (Zfp-42) and PAX-6 (Paired Box Protein-6), expressed by stem cells under the control of Oct-4, Sox-2 and Nanog.
Materials and methods
In this experimental study, a comparison, in terms of phenotype and gene expression, among three different extraembryonic tissues -chorionic villi (CV), amniotic fluid (AF) and placentawas carried out.
CV and AF samples were obtained from 30 pregnant women for each group, aged 23-45 years, from the 11th to 14th and the 15th to 21st weeks respectively. The patients underwent chorionic villus sampling (CVS) and amniocentesis to look for chromosomal abnormalities. The great majority of the samples analyzed came from healthy pregnancies. Only 3 samples out of 60 (5%) had a trisomy (trisomy 21). No difference in terms of immunophenotypic and gene expression analysis was found between the healthy pregnancies and those with chromosomal abnormalities. The placental samples were obtained from 10 pregnant women, aged 25-39 years and derived from elective caesarean sections, carried out around 38 weeks of gestation.
The study was approved by the local Ethics Committee (''Ethics Committee of ANDROS Day Surgery, Palermo, Approval date: November 15, 2010, Reference number 03/MR/10'').
CV was first mechanically fragmented and then enzymatically digested using pronase (Merck) and collagenase (Sigma) for 15 min for both phases. Enzyme activity was arrested with Hank's Balanced Salts solution (Sigma). Cells were plated in non-coated 25 cm 2 polystyrene culture flasks in Chang Medium (Irvine Scientific), a complete culture medium supplemented with penicillin, streptomycin, amphotericin, 10% fetal bovine serum (FBS) and glutamine (EuroClone). AF samples, obtained from amniocentesis, were centrifuged at 1400 RPM for 10 min. Cells were then plated in non-coated 25 cm 2 polystyrene culture flasks in Chang Medium. All samples were collected in order to carry out prenatal diagnosis and were then used for the present study at the second passage of culture with the consent of each woman.
Placenta samples were first mechanically fragmented and then enzymatically digested using pronase (Merck) and collagenase (Sigma) for 30 min for each phase. Enzyme activity was arrested with culture media containing FBS, cells were counted and 5 Â 10 5 cells were plated in non-coated 25 cm 2 polystyrene culture flasks in Chang Medium (Irvine Scientific). These samples were also analyzed at the second passage of culture. In order to confirm the fetal origin of the placenta samples, a 16 autosomal STR DNA genotyping (D3S1358, D19S433, D2S1338, D16S539, D18S51, TH01, D21S11, vWA, D8S1179, FGA, SE33, D22S1045, D10S1248, D1S1656, D12S391, D2S441), carried out using Powerplex 17 ESI System (Promega), was performed.
Flasks from all samples were stored at 37 8C in a CO 2 incubator. Regarding placenta samples, non-adherent cells were removed and fresh medium was added after 48 h. Culture medium was replaced twice a week in all samples and cells were replaced after reaching 80% (about every week) confluence using trypsine/EDTA (Sigma). MSCs were initially investigated for the spindle-shape morphology, absence of contamination by pathogens and for their proliferative potential in culture.
Cells from all samples were evaluated for cell surface antigens expression by flow cytometry, performed by FACS CANTO II (BD Bioscience). Four lasers evaluated simultaneously the physical parameters, Forward Scatter (FSC) and Side Scatter (SSC), and the expression of six different surface antigens on a single tube. Cells from all samples were collected at confluence, pelleted, suspended in 100 ml of PBS at the concentration of 1 Â 10 4 cells/ml and stained with the antibodies. Cells were incubated in the dark for 15 min at room temperature. After incubation, cells were washed with PBS and suspended in 100 ml of PBS to be analyzed with Facs Canto II.
Cells were incubated with the following antibodies: CD13-FITC (Dako), CD90-PE (Beckman Coulter), CD73-PE, CD34-PerCP-CY5.5, CD117-PE-CY7, CD33-APC and CD45-APC-CY7 (BD Biosciences).
Flow cytometer settings were established using unstained cells. Cells were gated by FSC to eliminate debris. A minimum of 10,000 events was counted for each analysis. Some samples were assayed by flow cytometry at different culture passages to determine any changes in surface molecule expression.
Cells in culture were treated with PBS and 2Â RNA Nucleic Acid Purification Solution (Applied Biosystem) to lyse cells and preserve RNA. Total RNA was extracted by the platform ABI PRISM 6100 Nucleic Acid PrepStation (Applied Biosystem). The RNA concentration and purity were measured with a spectrophotometer by determining the absorbance ratio of 260 nm to 280 nm (>1.8). To assess the integrity, RNA fragments were resolved on a 1.2% agarose gel looking for subunits18S and 28S of rRNA. 1 mg of total RNA was then reverse-transcribed with High-Capacity cDNA Archive kit (Applied Biosystem). The reaction was performed in a thermocycler in a final volume of 12 ml (10 min at 25 8C, 60 min at 37 8C and 7 min at 4 8C).
Real-time quantitative PCR was conducted on a ABI Prism 7700 (Applied Biosystem). 2.5 ml of cDNA were added with the PCR master mix (Applied Biosystem) and the specific primers and probes (TaqMan Gene Expression Assay, Applied Biosystem). The specificity of qPCR products was guaranteed by Applied Biosystem, which checks the specificity of primers and probes. Each sample of cDNA from different cell lines (CV,
Concerning statistical analysis, data from real-time quantitative PCR were analyzed by the non-parametric Kruskal-Wallis test using the software XLSTAT and then validated by the Relative Expression Software Tool (REST), to estimate fold changes among samples. Each gene was defined with a different expression when estimated p-value was <0.05. To increase the stability of the results, we applied filtering criteria that included mRNA, which were reliably quantifiable (cut off <30 Ct for the housekeeping gene). Undetermined values of Ct were estimated as 50 Ct (the last cycle of the reactions).
Results
Thirty samples of CV and 30 samples of AF were obtained for this study at the end of the second passage of culture and they were tested after reaching the second confluence. Ten placenta samples were isolated from the fresh tissue and they were maintained in culture up to the second confluence in order to remove differences among samples. Table 1 indicates the mean age of the patients and the mean week of sampling for each group. Four samples from all sources were maintained in culture for over a month to evaluate the behaviour of these cells. We observed that cells from different fetal sources are easy to expand in vitro and show a fibroblast-like morphology, consistent with that of typical MSCs.
Fetal stem cells from all samples were firstly characterized by flow cytometry for the expression of 7 cell surface antigens (CD13, CD90, CD73, CD34, CD117, CD33 and CD45) in order to better characterize MSCs.
MSCs from CV, AF and placentas were clearly negative for the expression of the haematopoietic surface antigens CD34, CD117, CD33 and CD45, while they expressed the typical MSCs antigens CD13, CD73 and CD90 at high fluorescence intensity (Fig. 1, boxes A, B, and C) [20] . Some samples of AF showed a specific cell population which expressed the MSCs markers CD73 and CD90 at different fluorescence intensities (Fig. 1, box D) . Furthermore, the same heterogeneity was found for the placenta samples. No differences were found in analyzed samples at different passages of culture, indicating that MSCs phenotypic characteristics are not lost during different phases of cultures (data not shown).
Real-time PCR was performed on 30 CV samples, 30 AF samples and 10 placenta samples at the end of the second confluence. The expression of the five genes investigated, OCT-4, SOX-2, NANOG, REX-1 and PAX-6, was related to the expression of the housekeeping gene GAPDH which indicates the success of cDNA synthesis. Some samples were discarded for statistical analysis because of the poor quality of the real-time PCR data. As a result of these limitations, 29 samples of CV, 27 samples of AF and 6 samples of placenta were used for gene expression analysis.
We estimated the DCt as the difference between Ct of each target gene and Ct of GAPDH, as control gene. A lower DCt indicates a higher expression of the gene and a higher DCt indicates a lower expression of the gene. The expression of the five genes analyzed was quite heterogeneous among samples within the same fetal source. Table 2 summarizes the mean DCt values of the three sources obtained from real-time PCR.
The Kruskal-Wallis test showed that there were no significant differences in terms of gene expression among all MSCs for the master genes OCT-4 (p-value = 0.15), SOX-2 (p-value = 0.32) and NANOG (p-value = 0.89), whereas REX-1 and PAX-6 genes were found to be differently expressed among CV, AF and placenta samples in terms of median with statistical significance (pvalue = 0.04 for PAX-6 and p-value = 0.02 for REX-1).
Comparisons among groups were conducted by the software REST. Graphical output of the results is presented in the box plots (Fig. 2) . In order to interpret these, it is important to keep in mind that a greater asymmetry in the position of the box in respect to the whiskers represents a greater difference in gene expression. Expression of genes REX-1 and PAX-6 was found significantly higher in AF samples (p = 0.004 for REX-1 and p = 0.0001 for PAX-6) compared with CV samples (substantial negative asymmetry). Expression of REX-1 and PAX-6 was higher in AF compared with placenta samples (slight negative asymmetry) and lower in CV samples compared with the placenta samples (slight positive asymmetry). In both cases these differences did not achieve significance (p-value = 0.081 for REX-1 and p-value = 0.414 for PAX-6 for AF vs placenta; p-value = 0.641 for REX-1 and p-value = 0.123 for PAX-6, for CV vs placenta).
Moreover, no significant changes in gene expression profile were observed by maintaining some samples in culture for over a month (Fig. 3 ).
Comments
As far as we know, this paper represents the first comparison among MSCs derived from different extra-embryonic tissues at different stages of human development. These MSCs showed no differences in morphology and growth characteristics when maintained in culture under the same conditions. Some samples of AF and placenta showed a heterogeneous phenotype as demonstrated by flow cytometry in which AF and placenta samples expressed CD73 and CD90 at different fluorescence intensity. Fig . 2 . The results were obtained by the software REST. Box A shows a significant negative asymmetry for REX-1 in CV samples, using AF as the 'control group' (p = 0.004). This asymmetry indicates that the gene expression of REX-1 was higher in AF samples. Box B shows a significant negative asymmetry for PAX-6 in CV samples, using AF as the 'control group' (p = 0.0001). This negative asymmetry indicates a higher expression of PAX-6 in AF samples.
This observation reflects the heterogeneity of the tissue of origin [21] , consisting of multiple cell types derived from fetal and maternal tissues [22, 23] . In particular, AF cells derive from both extra-embryonic and embryonic tissues [24] . The general consensus is that AF cells mainly consist of fetal cells shed in the amniotic cavity from the developing skin, respiratory apparatus, urinary and gastrointestinal tracts [25] .
Cells from all samples were analyzed for the expression of OCT-4, SOX-2, NANOG, REX-1 and PAX-6 genes, which are important for the maintenance of stem potential [26, 27] . The differences in expression of OCT-4, SOX-2 and NANOG genes were not significant, demonstrating that all fetal sources are equally suitable for obtaining MSCs.
An up-regulation was found for REX-1 and PAX-6 genes in the AF compared to CV.
REX-1 is a gene expressed in ESCs and its expression appears to be regulated by Oct-4, Sox-2 and Nanog. Rex-1 is a marker for a subpopulation of undifferentiated embryonic cells [28] and acts to reduce differentiation in ESCs [29] . Furthermore, REX-1 expression in mice decreases at the beginning of differentiation, during the embryo development [30] . The higher significant expression of this gene in AF samples could be related to the capacity of limiting the differentiation of MSCs. In the period of ontological development in which amniocentesis is carried out, the differentiation process is progressively reducing and this phenomenon could explain the significant higher expression of REX-1 in AF (p = 0.004) in comparison with CV. On the other hand, during the period at which CVS is performed, the differentiation process is entirely active and REX-1 expression is consequently low. REX-1 expression is also higher in placentas compared with CV, though without statistical significance.
PAX-6 is a master gene involved in ectodermal differentiation, particularly in the development of the eye [31] . The development of the eye temporally coincides with the amniocentesis and this could be the reason of its higher expression in AF samples. The temporally limited expression of PAX-6 is also, indirectly, demonstrated by the fact that placenta samples show lower expression of this gene, with a trend towards the statistical significance, in comparison to AF (Table 2) . We believe that PAX-6 expression is not enhanced in placenta as the eye has already developed.
Thus, the evidence of a higher expression in AF of REX-1 and PAX-6 may be correlated to a more advanced gestational age, in which these genes are activated.
The non-significance of the three master genes (OCT-4, SOX-2 and NANOG), among the different tissues, is an unexpected result. This finding, however, is important experimental knowledge which can allow the clinical use of those MSCs derived from the simplest achievable source, which could be the placenta, as this is a discarded tissue.
Our experimental results need to be confirmed and validated in larger studies but we believe that the field of MSCs obtained from extra-embryonic tissues should be expanded for future possible applications in regenerative medicine. 
